Opioid Induced Constipation Market to Witness a Healthy CAGR of 4.6% with USD $ 3.93 Billion by 2032

𝐎𝐩𝐢𝐨𝐢𝐝-𝐈𝐧𝐝𝐮𝐜𝐞𝐝 𝐂𝐨𝐧𝐬𝐭𝐢𝐩𝐚𝐭𝐢𝐨𝐧 (𝐎𝐈𝐂) 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:

Opioid-induced constipation refers to constipation that occurs as a side effect of opioid medications used for pain management. The market for OIC treatment involves pharmaceutical interventions and other therapeutic approaches to alleviate constipation while continuing opioid therapy.

The global opioid induced constipation market size is expected to reach USD 3.93 billion by 2032, according to a new study by Polaris Market Research. The report "Opioid Induced Constipation Market Share, Size, Trends, Industry Analysis Report, By Active Ingredients; By Prescription Type; By Route of Administration; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Opioids are most used to get relief from pain, as they include morphine and fentanyl. The increased accessibility of painkillers at retail and online e-commerce platforms is showing a positive impact on the demand for opioids in the marketplace, including significant growth potential for opioid-induced constipation.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 @https://www.polarismarketresearch.com/industry-analysis/opioid-induced-constipation-market/request-for-sample

The rising awareness campaigns by pharmaceutical companies, governments, and non-government agencies are demonstrating a positive impact on the opioid-induced constipation market. For instance, in 2023, Salix Pharmaceuticals, a drug manufacturer, along with the other two non-profit organisations, declared December 5 as the opioid-induced constipation awareness day to confront the stigmas surrounding the issue.

The rising use of opioids among the larger consumer base is expected to boost demand for opioid-induced constipation treatment. According to the available data, among the individuals who consumed opioids without cancer, around 40-60% of the people get opioid-induced constipation (OIC).

The higher risk of constipation with the intake of opioid-related drugs, along with the growing research studies to review the potential causes and suitable treatments, are showing wider growth opportunities for the market. For instance, a study published in the National Library of Medicine explored opioid-induced constipation and reviewed potential therapeutic and non-therapeutic treatments to treat the disease.

Furthermore, the use of opioids can be related to the rising use by cancer patients to get pain relief. According to pharmaceutical experts, approximately 60 to 90% of patients who took the opioid for cancer treatment suffered from opioid-induced constipation. Opioid-induced constipation patients are likely to face more difficulties in day-to-day life activities, primarily those facing cancer pain.

Moreover, research activities are positively influencing the creation of effective treatments for patients suffering from opioid-induced constipation. For instance, a 2024 study focused on finding the relationship between opioid-induced constipation and the P2Y1 receptor in the colonic myenteric plexus of rats.

𝐆𝐫𝐨𝐰𝐭𝐡 𝐃𝐫𝐢𝐯𝐞𝐫𝐬:

𝐈𝐧𝐜𝐫𝐞𝐚𝐬𝐞𝐝 𝐏𝐫𝐞𝐬𝐜𝐫𝐢𝐩𝐭𝐢𝐨𝐧 𝐨𝐟 𝐎𝐩𝐢𝐨𝐢𝐝 𝐌𝐞𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬:

The widespread use of opioid medications for pain management, including chronic pain conditions, post-surgery recovery, and cancer-related pain, contributes to the prevalence of opioid-induced constipation. The rising prescription rates of opioids drive the demand for effective OIC treatments.

𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐦𝐞𝐧𝐭𝐬 𝐢𝐧 𝐎𝐈𝐂 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐎𝐩𝐭𝐢𝐨𝐧𝐬:

Ongoing research and development efforts have led to the introduction of new and more effective treatments for opioid-induced constipation. Novel pharmaceuticals, such as peripherally acting mu-opioid receptor antagonists (PAMORAs), and other therapeutic interventions provide patients and healthcare professionals with a broader range of options.

𝐆𝐫𝐨𝐰𝐢𝐧𝐠 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬 𝐚𝐧𝐝 𝐄𝐝𝐮𝐜𝐚𝐭𝐢𝐨𝐧 𝐈𝐧𝐢𝐭𝐢𝐚𝐭𝐢𝐯𝐞𝐬:

Increasing awareness among healthcare providers and patients about the side effects of opioids, including opioid-induced constipation, has led to a higher demand for appropriate treatments. Educational initiatives and awareness campaigns contribute to early diagnosis and management of OIC.

𝐁𝐮𝐲 𝐭𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.polarismarketresearch.com/buy/3294/2

𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬:

𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐈𝐧𝐭𝐞𝐫𝐯𝐞𝐧𝐭𝐢𝐨𝐧𝐬:

Pharmaceutical solutions play a significant role in OIC treatment. Medications such as PAMORAs, which target opioid receptors in the gastrointestinal tract, are prescribed to alleviate constipation while maintaining pain management with opioids.

𝐋𝐢𝐟𝐞𝐬𝐭𝐲𝐥𝐞 𝐚𝐧𝐝 𝐃𝐢𝐞𝐭𝐚𝐫𝐲 𝐌𝐨𝐝𝐢𝐟𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬:

Non-pharmacological interventions, including dietary changes, increased fluid intake, and lifestyle modifications, are often recommended as part of OIC management. These measures aim to alleviate constipation symptoms and improve bowel regularity.

𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐄𝐝𝐮𝐜𝐚𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐒𝐮𝐩𝐩𝐨𝐫𝐭 𝐏𝐫𝐨𝐠𝐫𝐚𝐦𝐬:

Patient education and support programs provide information on the prevention and management of opioid-induced constipation. These programs may include counseling, resources, and tools to empower patients to actively participate in their treatment plans.

𝐎𝐩𝐢𝐨𝐢𝐝 𝐈𝐧𝐝𝐮𝐜𝐞𝐝 𝐂𝐨𝐧𝐬𝐭𝐢𝐩𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬

Naloxegol segment will grow at the fastest pace, due to its potential for treating opioid induced constipation issues.
Prescription segment held the largest share, owing to the rising importance of doctor consultation.

Oral segment dominated the market, primarily due to its ease of treatment intake and higher effectiveness.
Asia Pacific will register the fastest pace, attributable to the presence of the large proportion of elderly population.

The global players include Abbott, Aurobindo Pharma, Bayer, Boehringer Ingelheim International, & Bristol Myers Squibb Company.

𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐡𝐚𝐬 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐞𝐝 𝐭𝐡𝐞 𝐨𝐩𝐢𝐨𝐢𝐝 𝐢𝐧𝐝𝐮𝐜𝐞𝐝 𝐜𝐨𝐧𝐬𝐭𝐢𝐩𝐚𝐭𝐢𝐨𝐧 𝐦𝐚𝐫𝐤𝐞𝐭 𝐫𝐞𝐩𝐨𝐫𝐭 𝐛𝐚𝐬𝐞𝐝 𝐨𝐧 𝐚𝐜𝐭𝐢𝐯𝐞 𝐢𝐧𝐠𝐫𝐞𝐝𝐢𝐞𝐧𝐭𝐬, 𝐩𝐫𝐞𝐬𝐜𝐫𝐢𝐩𝐭𝐢𝐨𝐧 𝐭𝐲𝐩𝐞, 𝐫𝐨𝐮𝐭𝐞 𝐨𝐟 𝐚𝐝𝐦𝐢𝐧𝐢𝐬𝐭𝐫𝐚𝐭𝐢𝐨𝐧, 𝐝𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐜𝐡𝐚𝐧𝐧𝐞𝐥 𝐚𝐧𝐝 𝐫𝐞𝐠𝐢𝐨𝐧:

𝐎𝐩𝐢𝐨𝐢𝐝 𝐈𝐧𝐝𝐮𝐜𝐞𝐝 𝐂𝐨𝐧𝐬𝐭𝐢𝐩𝐚𝐭𝐢𝐨𝐧, 𝐀𝐜𝐭𝐢𝐯𝐞 𝐈𝐧𝐠𝐫𝐞𝐝𝐢𝐞𝐧𝐭𝐬 𝐎𝐮𝐭𝐥𝐨𝐨𝐤 (𝐑𝐞𝐯𝐞𝐧𝐮𝐞 - 𝐔𝐒𝐃 𝐁𝐢𝐥𝐥𝐢𝐨𝐧, 𝟐𝟎𝟏𝟗 - 𝟐𝟎𝟑𝟐)

Naloxegol
Lubiprostone
Methylnaltrexone Bromide
Docusate Sodium
Others

𝐎𝐩𝐢𝐨𝐢𝐝 𝐈𝐧𝐝𝐮𝐜𝐞𝐝 𝐂𝐨𝐧𝐬𝐭𝐢𝐩𝐚𝐭𝐢𝐨𝐧, 𝐏𝐫𝐞𝐬𝐜𝐫𝐢𝐩𝐭𝐢𝐨𝐧 𝐓𝐲𝐩𝐞 𝐎𝐮𝐭𝐥𝐨𝐨𝐤 (𝐑𝐞𝐯𝐞𝐧𝐮𝐞 - 𝐔𝐒𝐃 𝐁𝐢𝐥𝐥𝐢𝐨𝐧, 𝟐𝟎𝟏𝟗 - 𝟐𝟎𝟑𝟐)

Over The Counter Medicines
Prescription, Natural Remedies

𝐎𝐩𝐢𝐨𝐢𝐝 𝐈𝐧𝐝𝐮𝐜𝐞𝐝 𝐂𝐨𝐧𝐬𝐭𝐢𝐩𝐚𝐭𝐢𝐨𝐧, 𝐑𝐨𝐮𝐭𝐞 𝐨𝐟 𝐀𝐝𝐦𝐢𝐧𝐢𝐬𝐭𝐫𝐚𝐭𝐢𝐨𝐧 𝐎𝐮𝐭𝐥𝐨𝐨𝐤 (𝐑𝐞𝐯𝐞𝐧𝐮𝐞 - 𝐔𝐒𝐃 𝐁𝐢𝐥𝐥𝐢𝐨𝐧, 𝟐𝟎𝟏𝟗 - 𝟐𝟎𝟑𝟐)

Oral
Injectable
Others

𝐎𝐩𝐢𝐨𝐢𝐝 𝐈𝐧𝐝𝐮𝐜𝐞𝐝 𝐂𝐨𝐧𝐬𝐭𝐢𝐩𝐚𝐭𝐢𝐨𝐧, 𝐃𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐂𝐡𝐚𝐧𝐧𝐞𝐥 𝐎𝐮𝐭𝐥𝐨𝐨𝐤 (𝐑𝐞𝐯𝐞𝐧𝐮𝐞 - 𝐔𝐒𝐃 𝐁𝐢𝐥𝐥𝐢𝐨𝐧, 𝟐𝟎𝟏𝟗 - 𝟐𝟎𝟑𝟐)

Hospital Pharmacy
Online Pharmacy
Retail Pharmacy

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐮𝐬 𝐟𝐨𝐫 𝐒𝐩𝐞𝐜𝐢𝐚𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐚𝐧𝐝 𝐏𝐫𝐢𝐜𝐢𝐧𝐠 @ https://www.polarismarketresearch.com/industry-analysis/automotive-sensor-fusion-market/request-for-discount-pricing

𝐓𝐡𝐞 𝐆𝐞𝐨𝐠𝐫𝐚𝐩𝐡𝐢𝐜𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐂𝐨𝐯𝐞𝐫𝐬 𝐅𝐨𝐥𝐥𝐨𝐰𝐢𝐧𝐠 𝐊𝐞𝐲 𝐑𝐞𝐠𝐢𝐨𝐧𝐬:

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and the Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and the rest of South America)

The Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, South Africa, and the Rest of the Middle East and Africa)

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐌𝐨𝐫𝐞:

𝐏𝐨𝐰𝐝𝐞𝐫 𝐂𝐨𝐚𝐭𝐢𝐧𝐠 𝐄𝐪𝐮𝐢𝐩𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.linkedin.com/pulse/powder-coating-equipment-market-innovations-surface-finishing-harne-vf1hf

𝐒𝐮𝐩𝐞𝐫𝐡𝐲𝐝𝐫𝐨𝐩𝐡𝐨𝐛𝐢𝐜 𝐂𝐨𝐚𝐭𝐢𝐧𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.linkedin.com/pulse/superhydrophobic-coatings-market-innovating-solutions-mohit-harne-pdaxf

𝐖𝐨𝐨𝐝 𝐏𝐥𝐚𝐬𝐭𝐢𝐜 𝐂𝐨𝐦𝐩𝐨𝐬𝐢𝐭𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.linkedin.com/pulse/wood-plastic-composites-market-fusing-sustainability-durability-9hojf

𝐒𝐮𝐩𝐞𝐫 𝐀𝐛𝐬𝐨𝐫𝐛𝐞𝐧𝐭 𝐏𝐨𝐥𝐲𝐦𝐞𝐫 (𝐒𝐚𝐩) 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.linkedin.com/pulse/super-absorbent-polymer-sap-market-absorbing-various-industries-vzmif

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐈𝐧𝐟𝐨:

Polaris Market Research
30 Wall Street, 8th Floor,
New York City, NY 10005,
United States
Phone:+1-929 297-9727
Email: sales@polarismarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.

This release was published on openPR.